<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00929721</url>
  </required_header>
  <id_info>
    <org_study_id>6115A1-4000</org_study_id>
    <nct_id>NCT00929721</nct_id>
  </id_info>
  <brief_title>A Global Active Surveillance for Community Acquired Pneumonia</brief_title>
  <official_title>Global Active Surveillance for Community-Acquired Pneumonia (CAP) in Adults 50 Years and Older</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pfizer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is an observational surveillance study to identify adults 50 years and older who
      present to a study healthcare facility with signs and symptoms of Community-Acquired
      Pneumonia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2009</start_date>
  <completion_date type="Actual">February 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence rates of CAP in adults 50 years and older</measure>
    <time_frame>up to 120 days from enrollment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frequency of bacterial agents associated with CAP, Case fatality and incidence rates of CAP number and characteristics of subjects from outpatient clinics, emergency rooms, and hospital in-patient departments</measure>
    <time_frame>up to 120 days from enrollment</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">5172</enrollment>
  <condition>Community Acquired Pneumonia</condition>
  <arm_group>
    <arm_group_label>Subjects with Community-Acquired Pneumonia</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects with Community-Acquired Pneumonia</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Blood draw</intervention_name>
    <description>culture for Streptococcus pneumoniae Frequency-1</description>
    <arm_group_label>Subjects with Community-Acquired Pneumonia</arm_group_label>
    <other_name>Blood stick</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Chest X-ray</intervention_name>
    <description>image of the lungs to assess changes consistent with pneumonia Frequency-1</description>
    <arm_group_label>Subjects with Community-Acquired Pneumonia</arm_group_label>
    <other_name>Picture of lungs</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>urine specimen</intervention_name>
    <description>assay for the presence of Streptococcus pneumoniae Binax and UAD</description>
    <arm_group_label>Subjects with Community-Acquired Pneumonia</arm_group_label>
    <other_name>urine dipstick test</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Nasopharyngeal swab</intervention_name>
    <description>culture for Streptococcus pneumoniae Frequency-1</description>
    <arm_group_label>Subjects with Community-Acquired Pneumonia</arm_group_label>
    <other_name>swab from inside the nose and throat</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>sputum</intervention_name>
    <description>culture for Streptococcus pneumoniae Frequency-1</description>
    <arm_group_label>Subjects with Community-Acquired Pneumonia</arm_group_label>
    <other_name>collection secretions produced during cough</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult subjects 50 years of age or older

          -  Subject must reside in the surveillance area

          -  Subjects who present to a study healthcare facility where the treating physician
             clinically suspects CAP

        Exclusion Criteria:

          -  Any subject who is transferred to a study healthcare facility after already being
             hospitalized for 48 hours or more at any other in-patient facility (such as a
             community hospital).

          -  Hospital Acquired pneumonia (ie, develops signs and symptoms of pneumonia after being
             hospitalized for 48 hours or more).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pfizer CT.gov Call Center</last_name>
    <role>Study Director</role>
    <affiliation>Pfizer</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Chrzanow</city>
        <zip>32-500</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <removed_countries>
    <country>Korea, Republic of</country>
  </removed_countries>
  <link>
    <url>https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=6115A1-4000&amp;StudyName=A%20Global%20Active%20Surveillance%20for%20Community%20Acquired%20Pneumonia</url>
    <description>To obtain contact information for a study center near you, click here.</description>
  </link>
  <verification_date>April 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 26, 2009</study_first_submitted>
  <study_first_submitted_qc>June 26, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 29, 2009</study_first_posted>
  <last_update_submitted>April 12, 2012</last_update_submitted>
  <last_update_submitted_qc>April 12, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 13, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CAP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

